🔓 Unlock the full profile of Adar Poonawalla (Serum Institute Of India), including verified contact details, financial insights, and professional associations.
See Adar Poonawalla Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: ada*****@ser******.com
Mobile: 69435*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Adar Poonawalla was born on January 14, 1981, and is the CEO of Serum Institute of India (SII), a prominent vaccine manufacturer.
- He took over leadership at SII from his father, Dr. Cyrus S. Poonawalla, who founded the company in 1966.
- Under Adar's leadership, SII became the world's largest manufacturer of vaccines by volume, producing over 1.5 billion doses annually.
- Adar played a crucial role in the rapid development and distribution of the Covishield vaccine, an AstraZeneca COVID-19 vaccine variant, during the pandemic.
- He significantly expanded SII’s global presence, making vaccines accessible to low- and middle-income countries.
- Poonawalla has faced challenges such as supply chain disruptions and the critical task of managing vaccine production to meet global demand during health emergencies.
- He is also passionate about public health initiatives and is involved in projects related to sanitation and public health improvements.
- His foundation, the Poonawalla Foundation, aims to enhance healthcare, education, and environment sustainability across India.
| CIN/LLP | Company Name | Designation | Appointment Date |
|---|---|---|---|
| AAB-4041 | Genesis Parks Llp | Designated Partner | 15 Mar 2013 |
| AAC-0173 | Adar Estates Llp | Designated Partner | 21 Jan 2014 |
| AAQ-9680 | Sanoti Properties Llp | Designated Partner | 20 Oct 2021 |
| L51504PN1978PLC209007 | Poonawalla Fincorp Limited | Director | 01 Jun 2021 |
| U01409PN2006PTC022268 | Poonawalla Estates Stud And Agri Farm Privae Limited | Director | 31 Mar 2006 |
| U24100PN2019PTC188668 | Covidshield Technologies Private Limited | Director | 30 Sep 2021 |
| U24232MH2003PTC427275 | Sovereign Pharma Private Limited | Director | 28 May 2003 |
| U24290PN2020PTC191301 | Serum Institute Life Sciences Private Limited | Director | 30 Jun 2020 |
| U51101PN1993PLC072981 | Serum International Limited | Whole-time director | 08 Apr 2005 |
| U65100MH1985PTC035067 | Poonawalla Finance Private Limited | Director | 20 Jan 1999 |
| U65993MH1974PTC017311 | Poonawalla Investments And Industries Private Limited | Director | 24 Sep 1999 |
| U65993PN1993PTC070591 | Poonawalla Credit Private Limited | Director | 03 May 2018 |
| U67110PN1993PTC070989 | Rising Sun Holdings Pvt Ltd | Director | 10 Sep 2019 |
| U70102PN2005PTC021143 | Amron Realtors Private Limited | Director | 17 Aug 2005 |
| U74999PN2009PTC134929 | Villoo Poonawalla Racing & Breeding Private Limited | Director | 06 Nov 2009 |
| U80903PN1984PTC032945 | Serum Institute Of India Private Limited | Whole-time director | 01 Apr 2008 |
| U93110PN2025PTC237249 | Poonawalla Sports And Fitness Private Limited | Director | 20 Jan 2025 |
| CIN/LLP | Company Name | Designation | Appointment Date | End Date |
|---|---|---|---|
| U12140PN1994PTC075977 | Poonawalla Racing And Breeding Private Limited | Director | 30 Sep 2008| 04 February 2011 |
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Poonawalla Fincorp Ltd. | Chairman (Non-Executive) | 6 L | 20.0 % |
| 2023 | Poonawalla Fincorp Ltd. | Chairman (Non-Executive) | 5 L | 25.0 % |
| 2022 | Poonawalla Fincorp Ltd. | Chairman (Non-Executive) | 4 L | - |
| 2021 | Poonawalla Fincorp Ltd. | Chairman | - | - |